WELLlife Combo Test (Flu-A, Flu-B, and COVID-19)
The WELLlife COVID-19 / Influenza A&B Test differentiates between SARS-COV-2,
influenza A and influenza B antigens with a single test.
- Features and Benefits:
- Simultaneous detection of Flu-A, Flu-B, and COVID-19
- High sensitivity and specificity
- Streamlined workflow for efficient patient management
- Cost-effective - differentiate between SARS-COV-2, influenza A, and influenza B antigens with a single test using an anterior nasal swab specimen.
- Rapid - results available in 10 minutes allow for testing and treatment decision-making during the same office visit.
- Quality Assurance - the outstanding clinical performance, including built-in kit controls for external quality testing, enables physicians to make quicker and more confident decisions.
- Extended Detection Window - offers a broader detection window for differentiation of SARS-COV-2, influenza A, and influenza B antigens within five says of symptom onset.
- Wide Storage Temperature - 36°F-86°F (2°C-30°C) allows for easier product storage.
- Price is per box of 25. Packed 24 boxes per full case (600 tests per case). Must buy in boxes of 25 tests.
About Clarity Diagnostics, LLC
Clarity Diagnostics, LLC is a leading manufacturer of point of care rapid diagnostic tests, diagnostic equipment, and over-the-counter diagnostic tests that are targeted toward the Continuum of Care, Alternate Care, Acute Care, Laboratory, and OTC markets. As the industry's value leader, Clarity Diagnostics assists healthcare facilities and medical and testing professionals by helping increase regulatory compliance; reduce operating costs by offering significant savings versus other name brands; and helping create better patient experiences through easier diagnostic testing. The Clarity line of diagnostic solutions includes the following product categories: Urinalysis, Infectious Disease, Pregnancy Testing, Cancer Markers, Drugs of Abuse, Hemoglobin, and Glucose Testing.